ZYMERGEN INC (ZY) Stock Price & Overview

NASDAQ:ZY • US98985X1000

2.43 USD
+0.04 (+1.67%)
Last: Oct 18, 2022, 08:22 PM

The current stock price of ZY is 2.43 USD. Today ZY is up by 1.67%. In the past month the price decreased by -6.18%. In the past year, price decreased by -76.75%.

ZY Key Statistics

52-Week Range1.1 - 11.87
Current ZY stock price positioned within its 52-week range.
1-Month Range2.3 - 3.15
Current ZY stock price positioned within its 1-month range.
Market Cap
253.583M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.34
Dividend Yield
N/A

ZY Stock Performance

Today
+1.67%
1 Week
-8.65%
1 Month
-6.18%
3 Months
+21.50%
Longer-term
6 Months +36.52%
1 Year -76.75%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ZY Stock Chart

ZYMERGEN INC / ZY Daily stock chart

ZY Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ZY. When comparing the yearly performance of all stocks, ZY is a bad performer in the overall market: 73.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
ZY Full Technical Analysis Report

ZY Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ZY. While ZY seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ZY Full Fundamental Analysis Report

ZY Earnings

Next Earnings DateNov 11, 2022
Last Earnings DateAug 15, 2022
PeriodQ2 / 2022
EPS Reported-$1.13
Revenue Reported
EPS Surprise -48.26%
Revenue Surprise -20.33%
ZY Earnings History

ZY Forecast & Estimates

11 analysts have analysed ZY and the average price target is 2.35 USD. This implies a price decrease of -3.46% is expected in the next year compared to the current price of 2.43.

For the next year, analysts expect an EPS growth of 33.88% and a revenue growth -21.93% for ZY


Analysts
Analysts43.64
Price Target2.35 (-3.29%)
EPS Next Y33.88%
Revenue Next Year-21.93%
ZY Forecast & Estimates

ZY Groups

Sector & Classification

ZY Financial Highlights

Over the last trailing twelve months ZY reported a non-GAAP Earnings per Share(EPS) of -3.34. The EPS increased by 53.02% compared to the year before.


Income Statements
Revenue(TTM)14.55M
Net Income(TTM)-364.95M
Industry RankSector Rank
PM (TTM) -2508.94%
ROA -77.49%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%13.08%
Sales Q2Q%-55.01%
EPS 1Y (TTM)53.02%
Revenue 1Y (TTM)-22.23%
ZY financials

ZY Ownership

Ownership
Inst Owners5.74%
Shares104.36M
Float62.72M
Ins Owners6.26%
Short Float %N/A
Short RatioN/A
ZY Ownership

ZY Competitors/Peers

The largest stocks on the US markets in the "Commodity Chemicals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
DOW DOW INC N/A23.205B
WLK WESTLAKE CORP124.1213.575B
CBT CABOT CORP10.363.91B
HWKN HAWKINS INC32.943.157B
OLN OLIN CORP N/A2.78B
TROX TRONOX HOLDINGS PLC N/A1.169B
PCT PURECYCLE TECHNOLOGIES INC N/A1.12B
WLKP WESTLAKE CHEMICAL PARTNERS L11.7780.788M
KOP KOPPERS HOLDINGS INC8.36757.122M
KRO KRONOS WORLDWIDE INC87.28664.989M
MATV MATIV HOLDINGS INC9.25548.44M
ASIX ADVANSIX INC9.97531.291M
CMT CORE MOLDING TECHNOLOGIES IN11.24165.294M

About ZY

Company Profile

ZY logo image Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. The company is headquartered in Emeryville, California and currently employs 507 full-time employees. The company went IPO on 2021-04-22. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.

Company Info

ZYMERGEN INC

5959 Horton Street, Suite 700

Emeryville CALIFORNIA US

Employees: 507

ZY Company Website

Phone: 14158018073.0

ZYMERGEN INC / ZY FAQ

What does ZY do?

Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. The company is headquartered in Emeryville, California and currently employs 507 full-time employees. The company went IPO on 2021-04-22. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.


What is the current price of ZY stock?

The current stock price of ZY is 2.43 USD. The price increased by 1.67% in the last trading session.


What is the dividend status of ZYMERGEN INC?

ZY does not pay a dividend.


How is the ChartMill rating for ZYMERGEN INC?

ZY has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the GICS sector and industry of ZY stock?

ZYMERGEN INC (ZY) operates in the Materials sector and the Chemicals industry.


What is the next earnings date for ZY stock?

ZYMERGEN INC (ZY) will report earnings on 2022-11-11, after the market close.